Delivery Order SPE2DR25D1104-SPE2DR26FL799
Award Date 4/15/26
Potential Completion Date 5/6/26
Potential Value $3.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 24, 2026, for Benlysta 200 mg/ml autoinjector, with a ceiling value of $6,973.34 and an ultimate completion date of April 14, 2026. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which provides a comprehensive global pharmaceutical support vehicle for supplying pharmaceutical products and medical...
- The Defense Logistics Agency issued a $3,486.67 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Benlysta 200 mg/ml auto-injector. Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of March 27, 2026. The delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supports pharmaceutical supply across military healthcare...
- The Defense Logistics Agency issued a $3,486.67 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Benlysta 200 mg/ml autoinjector. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The ultimate completion date is March 19, 2026. Pricing is firm fixed...
- The Defense Logistics Agency issued a $3,486.67 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for Benlysta 200 mg/ml auto-injector pharmaceutical supply. The order is placed against the parent IDC held with DLA Troop Support Medical, a $999,999,999 indefinite delivery contract extending through December 2026 that covers pharmaceutical products and medical supplies for military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order carries a firm...
- The Defense Logistics Agency issued a $3,486.67 delivery order to AmerisourceBergen Drug Corp on March 30, 2026, for Benlysta 200 mg/ml auto-injector. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price and is...
- The Defense Logistics Agency issued a $6,973.34 delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for Benlysta 200 mg/ml auto-injector pharmaceutical supply. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an...
- The Defense Logistics Agency issued a $3,486.67 delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for Benlysta 200 mg/ml autoinjector. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate...
- The Defense Logistics Agency issued a $3,486.67 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Benlysta 200 mg/ml auto-injector. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support globally for military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 15, 2026, for BENLYSTA 200 mg/ml auto-injector with a ceiling value of $6,973.34, under firm fixed-price terms. Place of performance is Conshohocken, PA 19428. Ultimate completion date is May 6, 2026. This delivery order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which enables supply of pharmaceutical...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 17, 2026, with a ceiling value of $3,486.67 for Benlysta 200 mg/ml auto-injector supply. Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999 through December 2026, enabling supply of pharmaceutical products and medical commodities to...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL799Delivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 15, 2026, for Benlysta 200 mg/ml auto-injector with a ceiling value of $3,486.67 and firm fixed pricing. Place of performance is Conshohocken, PA. The order's ultimate completion date is May 6, 2026. This delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as a global pharmaceutical supply vehicle supporting military healthcare programs.
Generated 7/14/26, 10:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/14/26 |